![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | FOXD1 | Human | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | increases expression | EXP | | 6480464 | o and p'-DDT results in increased expression of FOXD1 mRNA | CTD | PMID:19371625 | FOXD1 | Human | 1,1-dichloroethene | decreases expression | ISO | Foxd1 (Mus musculus) | 6480464 | vinylidene chloride results in decreased expression of FOXD1 mRNA | CTD | PMID:26682919 | FOXD1 | Human | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of FOXD1 mRNA | CTD | PMID:23019147 | FOXD1 | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of FOXD1 mRNA | CTD | PMID:30165855 | FOXD1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Foxd1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of FOXD1 mRNA | CTD | PMID:24058054 | FOXD1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Foxd1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FOXD1 mRNA | CTD | PMID:33387578 | FOXD1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of FOXD1 mRNA | CTD | PMID:22574217 | FOXD1 | Human | 4,4'-sulfonyldiphenol | increases expression | EXP | | 6480464 | bisphenol S results in increased expression of FOXD1 mRNA | CTD | PMID:30616060 | FOXD1 | Human | 4,4'-sulfonyldiphenol | increases expression | ISO | Foxd1 (Mus musculus) | 6480464 | bisphenol S results in increased expression of FOXD1 mRNA | CTD | PMID:30951980 | FOXD1 | Human | ammonium chloride | affects expression | ISO | Foxd1 (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of FOXD1 mRNA | CTD | PMID:16483693 | FOXD1 | Human | arsane | multiple interactions | EXP | | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FOXD1 mRNA more ... | CTD | PMID:32525701 and PMID:39836092 | FOXD1 | Human | arsenic atom | multiple interactions | EXP | | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FOXD1 mRNA more ... | CTD | PMID:32525701 and PMID:39836092 | FOXD1 | Human | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of FOXD1 3' UTR | CTD | PMID:27901495 | FOXD1 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of FOXD1 promoter | CTD | PMID:27901495 | FOXD1 | Human | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:20382639 | FOXD1 | Human | bis(2-ethylhexyl) phthalate | decreases expression | ISO | Foxd1 (Rattus norvegicus) | 6480464 | Diethylhexyl Phthalate results in decreased expression of FOXD1 mRNA | CTD | PMID:22677342 | FOXD1 | Human | bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of FOXD1 mRNA | CTD | PMID:31163220 | FOXD1 | Human | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of FOXD1 mRNA | CTD | PMID:19371625 | FOXD1 | Human | bisphenol A | increases expression | ISO | Foxd1 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of FOXD1 mRNA | CTD | PMID:36779543 | FOXD1 | Human | bisphenol A | increases expression | ISO | Foxd1 (Mus musculus) | 6480464 | bisphenol A results in increased expression of FOXD1 mRNA | CTD | PMID:30951980 | FOXD1 | Human | bisphenol A | affects methylation | ISO | Foxd1 (Mus musculus) | 6480464 | bisphenol A affects the methylation of FOXD1 promoter | CTD | PMID:27334623 | FOXD1 | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of FOXD1 mRNA | CTD | PMID:20678512 and PMID:29275510 | FOXD1 | Human | bisphenol F | increases expression | ISO | Foxd1 (Mus musculus) | 6480464 | bisphenol F results in increased expression of FOXD1 mRNA | CTD | PMID:30951980 | FOXD1 | Human | cannabidiol | increases expression | EXP | | 6480464 | Cannabidiol results in increased expression of FOXD1 mRNA | CTD | PMID:33244087 | FOXD1 | Human | carbamazepine | affects expression | EXP | | 6480464 | Carbamazepine affects the expression of FOXD1 mRNA | CTD | PMID:25979313 | FOXD1 | Human | choline | multiple interactions | ISO | Foxd1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FOXD1 gene | CTD | PMID:20938992 | FOXD1 | Human | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of FOXD1 mRNA | CTD | PMID:27392435 | FOXD1 | Human | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of FOXD1 mRNA | CTD | PMID:27392435 | FOXD1 | Human | cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of FOXD1 mRNA | CTD | PMID:19376846 | FOXD1 | Human | coumestrol | decreases expression | EXP | | 6480464 | Coumestrol results in decreased expression of FOXD1 mRNA | CTD | PMID:19167446 | FOXD1 | Human | crocidolite asbestos | increases expression | EXP | | 6480464 | Asbestos and Crocidolite results in increased expression of FOXD1 mRNA | CTD | PMID:18687144 | FOXD1 | Human | cyclosporin A | decreases methylation | EXP | | 6480464 | Cyclosporine results in decreased methylation of FOXD1 promoter | CTD | PMID:27989131 | FOXD1 | Human | DDE | increases expression | EXP | | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of FOXD1 mRNA | CTD | PMID:38568856 | FOXD1 | Human | diallyl trisulfide | increases expression | EXP | | 6480464 | diallyl trisulfide results in increased expression of FOXD1 mRNA | CTD | PMID:34995734 | FOXD1 | Human | diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of FOXD1 mRNA | CTD | PMID:19371625 | FOXD1 | Human | entinostat | increases expression | EXP | | 6480464 | entinostat results in increased expression of FOXD1 mRNA | CTD | PMID:27188386 | FOXD1 | Human | folic acid | multiple interactions | ISO | Foxd1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FOXD1 gene | CTD | PMID:20938992 | FOXD1 | Human | genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of FOXD1 mRNA | CTD | PMID:19371625 | FOXD1 | Human | gentamycin | increases expression | ISO | Foxd1 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of FOXD1 mRNA | CTD | PMID:33387578 | FOXD1 | Human | hydrazine | decreases expression | ISO | Foxd1 (Mus musculus) | 6480464 | hydrazine results in decreased expression of FOXD1 mRNA | CTD | PMID:15282401 | FOXD1 | Human | isotretinoin | increases expression | EXP | | 6480464 | Isotretinoin results in increased expression of FOXD1 mRNA | CTD | PMID:20436886 | FOXD1 | Human | L-methionine | multiple interactions | ISO | Foxd1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FOXD1 gene | CTD | PMID:20938992 | FOXD1 | Human | Licochalcone B | increases expression | EXP | | 6480464 | licochalcone B results in increased expression of FOXD1 mRNA | CTD | PMID:33647349 | FOXD1 | Human | manganese atom | multiple interactions | EXP | | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FOXD1 mRNA | CTD | PMID:39836092 | FOXD1 | Human | manganese(0) | multiple interactions | EXP | | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FOXD1 mRNA | CTD | PMID:39836092 | FOXD1 | Human | manganese(II) chloride | multiple interactions | EXP | | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FOXD1 mRNA | CTD | PMID:39836092 | FOXD1 | Human | N-nitrosodiethylamine | multiple interactions | ISO | Foxd1 (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of FOXD1 mRNA | CTD | PMID:20360939 | FOXD1 | Human | nickel atom | decreases expression | EXP | | 6480464 | Nickel results in decreased expression of FOXD1 mRNA | CTD | PMID:25583101 | FOXD1 | Human | paracetamol | affects expression | ISO | Foxd1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of FOXD1 mRNA | CTD | PMID:17562736 | FOXD1 | Human | paracetamol | increases expression | ISO | Foxd1 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of FOXD1 mRNA | CTD | PMID:33387578 | FOXD1 | Human | phenethyl caffeate | multiple interactions | ISO | Foxd1 (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of FOXD1 mRNA | CTD | PMID:20360939 | FOXD1 | Human | resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of FOXD1 mRNA | CTD | PMID:19371625 | FOXD1 | Human | rofecoxib | decreases expression | EXP | | 6480464 | rofecoxib results in decreased expression of FOXD1 mRNA | CTD | PMID:17070997 | FOXD1 | Human | silver atom | decreases expression | ISO | Foxd1 (Mus musculus) | 6480464 | Silver results in decreased expression of FOXD1 mRNA | CTD | PMID:27131904 | FOXD1 | Human | silver(0) | decreases expression | ISO | Foxd1 (Mus musculus) | 6480464 | Silver results in decreased expression of FOXD1 mRNA | CTD | PMID:27131904 | FOXD1 | Human | sodium arsenate | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of FOXD1 mRNA | CTD | PMID:32525701 | FOXD1 | Human | sodium arsenite | multiple interactions | EXP | | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FOXD1 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FOXD1 mRNA | CTD | PMID:39836092 | FOXD1 | Human | temozolomide | decreases expression | EXP | | 6480464 | Temozolomide results in decreased expression of FOXD1 mRNA | CTD | PMID:31758290 | FOXD1 | Human | tert-butyl hydroperoxide | decreases expression | ISO | Foxd1 (Mus musculus) | 6480464 | tert-Butylhydroperoxide results in decreased expression of FOXD1 mRNA | CTD | PMID:15003993 | FOXD1 | Human | tert-butyl hydroperoxide | increases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in increased expression of FOXD1 mRNA | CTD | PMID:15336504 | FOXD1 | Human | titanium dioxide | decreases methylation | ISO | Foxd1 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of FOXD1 promoter | CTD | PMID:35295148 | FOXD1 | Human | titanium dioxide | increases methylation | ISO | Foxd1 (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of FOXD1 enhancer | CTD | PMID:35295148 | FOXD1 | Human | topotecan | affects response to substance | EXP | | 6480464 | FOXD1 protein affects the susceptibility to Topotecan | CTD | PMID:16217747 | FOXD1 | Human | trichloroethene | increases expression | ISO | Foxd1 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of FOXD1 mRNA | CTD | PMID:33387578 | FOXD1 | Human | urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of FOXD1 mRNA | CTD | PMID:28818685 | FOXD1 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of FOXD1 mRNA | CTD | PMID:25979313 | FOXD1 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of FOXD1 mRNA | CTD | PMID:23179753 and PMID:27188386 | FOXD1 | Human | valproic acid | increases expression | ISO | Foxd1 (Mus musculus) | 6480464 | Valproic Acid results in increased expression of FOXD1 mRNA | CTD | PMID:24896083 | FOXD1 | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of FOXD1 gene | CTD | PMID:29154799 | FOXD1 | Human | zearalenone | increases expression | EXP | | 6480464 | Zearalenone results in increased expression of FOXD1 mRNA | CTD | PMID:19371625 | FOXD1 | Human | zinc atom | increases expression | EXP | | 6480464 | Zinc results in increased expression of FOXD1 mRNA | CTD | PMID:16870260 | FOXD1 | Human | zinc dichloride | increases expression | EXP | | 6480464 | zinc chloride results in increased expression of FOXD1 mRNA | CTD | PMID:16870260 | FOXD1 | Human | zinc(0) | increases expression | EXP | | 6480464 | Zinc results in increased expression of FOXD1 mRNA | CTD | PMID:16870260 | |